Lupin launches generic drug for treatment of Pulmonary disease

Arformoterol tartrate inhalation solution 15 mcg/2 mL, is indicated for chronic obstructive pulmonary disease

53
Medicine
Picture: Pixabay

Global pharma major, Lupin Limited, announced the launch of the authorized generic version of Brovana (arformoterol tartrate) inhalation solution 15 mcg/2 mL, unit-dose vials, of Sunovion Pharmaceuticals Inc.

Arformoterol tartrate inhalation solution 15 mcg/2 mL, is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is for use by nebulization only.

ICMR approved Self-test kit for C-19 launched

Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

Glenmark launches drug for the treatment of seizures

Celon launches an emulsion-based drug to treat Black Fungus

JB Chemicals launches medicated Nicotine lozenges: Quit smoking

Merck launches synthetic cholesterol product

ICMR approved Self-test kit for C-19 launched

Serum Institute seeks DCGI’s nod to manufacture Sputnik V vaccine

Black fungus drug: Black marketing Racket busted

Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets

Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

USFDA accepts application from Lupin for Pegfilgrastim Biosimilar

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner